Novartis (NYSE:NVS)

Pills

Akebia, MediWound Post Gains Following IPOs

Mediwound Ltd. (NASDAQ: MDWD) is an Israel-based biopharma firm that is developing, manufacturing and commercializing novel products to address severe burns and other hard-to-heal wounds and connective tissue disorders. The ...
Read Full Story »
biotech

Biotech Buyout Bolsters Novartis Cancer Portfolio

Pharmaceutical giant Novartis A.G. (NYSE: NVS) announced Monday morning that it will acquire startup biotech CoStim Pharmaceuticals. Terms of the deal were not revealed, but it will bolster Novartis's cancer ...
Read Full Story »
Pills

Novartis Announces Share Buybacks and Business Expansion

Speculation has run hot that Swiss drugmaker Novartis A.G. (NYSE: NVS) would announced further restructuring at its investor day in London. Instead, on Friday the company announced a $5 billion ...
Read Full Story »
Pills

Shire, Novartis Deals: Pharmaceutical Shakeups Continue

The wave of mergers and acquisitions in health care continues with two big announcements Monday. Drug maker Shire PLC (NASDAQ: SHPG) will acquire the rare disease biopharmaceutical company ViroPharma (NASDAQ: ...
Read Full Story »
biotech

Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas

Investors make big money in biotechnology stocks when they focus on areas that cut across a wide swath of the population. From obesity to food allergies to prostate cancer, the ...
Read Full Story »
global economy

UBS Offers Eight Well-Known International Large Cap Dividend Ruler Stocks

With yields on 10-year Treasury bonds up nearly 1.5% since early May and briefly touching 3.0% last week, the impact of higher rates on stocks continues to be top of ...
Read Full Story »
pills

Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx

Although Amgen Inc.’s (NASDAQ: AMGN) $10 billion offer for Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) was unsolicited and not exactly a stalking horse bid, that’s what many observers expect to be ...
Read Full Story »
Pills

Jefferies Raises Price Targets on Pharmaceutical Stocks to Buy

As the pharmaceuticals industry looks toward restructuring and separation of undervalued assets, Jefferies analysts have prepared a highly proprietary sum of the parts analysis for their coverage universe to find ...
Read Full Story »
Pills

Jefferies Top Global Pharmaceutical Stock Picks for 2013 (JEF, ABBV, NVS, SNY, PFE)

After a strong year of relative performance for pharmaceutical stocks in 2012, the analysts at Jefferies Group Inc. (NYSE: JEF) predict that 2013 could show more of the same. However ...
Read Full Story »

Ranking Innovation: Who’s Number 1?

In its third annual ranking of the world’s most innovative companies, analysts at Booz & Co. created two lists: one based on dollars spent and the other based on asking ...
Read Full Story »

Media Digest (7/19/2012) Reuters, WSJ, NYT, FT, Bloomberg

A new consumer agency fines Capital One (NYSE: COF) $210 million for aggressive marketing activity.(Reuters) New IMF policies will examine whether individual national economies might hurt global growth. (Reuters) IBM (NYSE: ...
Read Full Story »

Media Digest (3/8/2012) Reuters, WSJ, NYT, FT, Marketwatch

The CEO of Chrysler said he took no pay in 2011 and that, based on financial results, the company is now worth $7.5 billion. (Reuters) The Treasury will sell $6 ...
Read Full Story »

In Layoff Wave, a New Threat of Economic Retreat

The public and the press usually measure unemployment one month at a time as data from ADP and the federal government are issued. The jobs market can also be tracked ...
Read Full Story »

What’s Important in the Financial World (1/13/2012) iPhone Riots, Goldman Oil Price Forecast

Layoffs have surged recently. There is no telling why they happened all at about the same time. Drug giant Novartis (NYSE: NVS) said it will cut nearly 2,000 jobs. Food ...
Read Full Story »

Media Digest (1/13/2012) Reuters, WSJ, NYT, FT, Bloomberg

TPG may invest $1 billion in troubled Olympus. (Reuters) President Obama to ask for a $1.2 trillion increase in the national debt ceiling. (Reuters) China’s foreign currency reserves drop to ...
Read Full Story »